Search Results - "Njenda, Duncan"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness by van Domselaar, Robert, Njenda, Duncan T, Rao, Rohit, Sönnerborg, Anders, Singh, Kamalendra, Neogi, Ujjwal

    Published in Journal of virology (01-05-2019)
    “…Human immunodeficiency virus type 1 subtype C (HIV-1C) has a natural deletion of a YPxL motif in its Gag-p6 late domain. This domain mediates the binding of…”
    Get full text
    Journal Article
  2. 2

    Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes by Neogi, Ujjwal, Singh, Kamalendra, Aralaguppe, Shambhu G, Rogers, Leonard C, Njenda, Duncan T, Sarafianos, Stefan G, Hejdeman, Bo, Sönnerborg, Anders

    Published in AIDS (London) (20-02-2018)
    “…OBJECTIVE:To determine the antiretroviral activity of the integrase strand transfer inhibitors (INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir…”
    Get full text
    Journal Article
  3. 3

    Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes by Njenda, Duncan T, Aralaguppe, Shambhu G, Singh, Kamalendra, Rao, Rohit, Sönnerborg, Anders, Sarafianos, Stefan G, Neogi, Ujjwal

    Published in Journal of antimicrobial chemotherapy (01-10-2018)
    “…4'-Ethnyl-2'-fluoro-2'-deoxyadenosine (EFdA) is a novel translocation-defective reverse transcriptase inhibitor. We investigated the virological and…”
    Get full text
    Journal Article
  4. 4

    Strain-specific effect on biphasic DNA binding by HIV-1 integrase by Hill, Kyle J, Rogers, Leonard C, Njenda, Duncan T, Burke, Donald H, Sarafianos, Stefan G, Sönnerborg, Anders, Neogi, Ujjwal, Singh, Kamalendra

    Published in AIDS (London) (01-03-2019)
    “…The oligomerization of HIV-1 integrase onto DNA is not well understood. Here we show that HIV-1 integrase binds the DNA in biphasic (high-affinity and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    From Bedside to Bench and Back: Future Options for Antiretroviral Drugs in Non-B HIV-1 Subtypes by Njenda, Duncan Tazvinzwa

    Published 01-01-2020
    “…HIV-1 drug resistance remains a burden in low- and middle-income countries (LMIC).Regardless of the advances in antiretroviral (ARV) therapy, there is an…”
    Get full text
    Dissertation
  9. 9

    Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaoundé, Cameroon by Ikomey, George Mondinde, Assoumou, Marie Claire Okomo, Gichana, Josiah Otwoma, Njenda, Duncan, Mikasi, Sello Given, Mesembe, Martha, Lyonga, Emilia, Jacobs, Graeme Brendon

    Published in Germs (Bucureşti) (01-12-2017)
    “…The emergence of drug resistance mutations (DRMs) has been a major threat for successful lifelong combination antiretroviral therapy (cART), especially for…”
    Get full text
    Journal Article